Entities / Company
Oncolytics Biotech.
Company
- Reports this week
- 0
- Active events
- 0
- Connections
- 16
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
Trump's policy benefits US stocks, citing Amazon.com and Oncolytics Biotech as examples of unprofitable businesses.Some support1 report
-
Oncolytics Biotech regained compliance with Nasdaq trading rules on July 23, 2025.Some support1 report
-
Oncolytics Biotech maintained its reporting issuer status in Canada on August 8, 2025.Some support1 report
-
The FDA granted Fast Track designation for treatments, and the company Oncolytics Biotech began using LinkedIn for its social media presence.Some support1 report
-
Oncolytics Biotech and Johnson & Johnson operate within the larger oncology ecosystem, with J&J setting market standards through successful acquisitions.Well supported4 reports3 developments inside
No events began in the chosen period. Widen it, or reset.
Around Oncolytics Biotech this week
News at the entities that move Oncolytics Biotech most-
FDA StructuralThe FDA approved a new manufacturing process for biosimilar by Alvotech, with Joseph McClellan serving as COO.Moves Oncolytics Biotech
-
Nasdaq StructuralCeriBell, Inc. traded on the Nasdaq stock exchange and filed insider transactions with the SEC on July 2, 2026.Moves Oncolytics Biotech
-
Merck KGaA OperationalNasdaq added Moderna to its Nasdaq-100 index, and Moderna combined its vaccine with Merck's drug.Moves Oncolytics Biotech
-
Johnson & Johnson OperationalFailures resulted in catastrophic reputational damage for several major companies, while others successfully used safety as a brand differentiator.Moves Oncolytics Biotech
Connections
The 4 strongest of 16, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
The FDA formally regulates Oncolytics Biotech by granting Fast Track designations to its trials and treatments.
-
Merck KGaA Operational
Oncolytics Biotech and Merck KGaA are engaged in a co-development agreement for the drug pelareorep.
-
Nasdaq Structural
Oncolytics Biotech is a publicly listed company trading on the Nasdaq exchange.
-
Johnson & Johnson Operational
they act on each other directly
History
Events by the month they beganJune 2026
5 events- Trump's policy benefits US stocks, citing Amazon.com and Oncolytics Biotech as examples of unprofitable businesses.
- Oncolytics Biotech regained compliance with Nasdaq trading rules on July 23, 2025.
- Oncolytics Biotech maintained its reporting issuer status in Canada on August 8, 2025.
- The FDA granted Fast Track designation for treatments, and the company Oncolytics Biotech began using LinkedIn for its social media presence.
- Oncolytics Biotech and Johnson & Johnson operate within the larger oncology ecosystem, with J&J setting market standards through successful acquisitions.